《MedRxiv,3月6日,68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-03-07
  • 68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit

    Nicholas Easom, Peter Moss, Gavin Barlow, Anda Samson, Tom Taynton, Kate Adams, Monica Ivan, Phillipa Burns, Kavitha Gajee, Kirstine Eastick, Patrick Lillie

    doi: https://doi.org/10.1101/2020.02.29.20029462

    Abstract

    Clinical assessment of possible infection with SARS-CoV-2, the novel coronavirus responsible for the outbreak of COVID-19 respiratory illness, has been a major activity of infectious diseases services in the UK and elsewhere since the first report of cases in December 2019. We report our case series of 68 patients, reviewed by Infectious Diseases Consultants at a Regional Infectious Diseases Unit in the UK. We prospectively evaluated our service between the 29th Jan 2020 and 24th Feb 2020. Demographic, clinical, epidemiological and laboratory data were collected. We have compared clinical features and subsequent diagnosis between well patients not requiring admission for clinical reasons or antimicrobials with those assessed as needing either admission or antimicrobial treatment.

    *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.

  • 原文来源:https://www.medrxiv.org/content/10.1101/2020.02.29.20029462v1
相关报告
  • 《MedRxiv,3月24日,Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-25
    • Infection Control of 2019 Novel Corona Virus Disease (COVID-19) in Cancer Patients undergoing Radiotherapy in Wuhan Conghua Xie, Xiaoyong Wang, Hui Liu, Zhirong Bao, Jing Yu, Yahua Zhong, Melvin LK Chua doi: https://doi.org/10.1101/2020.03.21.20037051 Abstract Background A pandemic of 2019 novel corona virus disease (COVID-19), which was first reported in Wuhan city, has affected more than 100,000 patients worldwide. Patients with cancer are at a higher risk of COVID-19, but currently, there is no guidance on the management of cancer patients during this outbreak. Here, we report the infection control measures and early outcomes of patients who received radiotherapy (RT) at a tertiary cancer centre in Wuhan. Methods We reviewed all patients who were treated at the Zhongnan Hospital of Wuhan University (ZHWU) from Jan 20 to Mar 6, 2020. This preceded the city lock-down date of Jan 23, 2020. Infection control measures were implemented, which included a clinical pathway for managing suspect COVID-19 cases, on-site screening, modifications to the RT facility, and protection of healthcare workers. *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用.
  • 《3月6日_英国一地区传染病部门提供了一份68名连续接受COVID-19感染评估的患者分析报告》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-03-07
    • 信息名称:英国一地区传染病部门提供了一份68名连续接受COVID-19感染评估的患者分析报告 1.时间:2020年3月6日 2.机构或团队:英国赫尔大学教学医院NHS信托基金 3.事件概要: 3月6日,medRxiv预印本发表了来自英国赫尔大学教学医院NHS信托基金研究团队的题为“68 Consecutive patients assessed for COVID-19 infection; experience from a UK regional infectious disease unit”的文章。 自2019年12月首次报告病例以来,可能感染SARS-CoV-2的临床评估一直是英国和其他地方传染病服务的一项主要活动。文章中研究者报告了68例患者的病例分析,由英国一个地区传染病部门的传染病咨询公司进行了回顾性研究。文章对2020年1月29日至2020年2月24日期间的患者服务进行了前瞻性评估,收集了人口统计学、临床学、流行病学和实验室数据。比较了不需要临床入院或抗菌药物的健康患者与那些被评估为需要入院或抗菌治疗的患者之间的临床特征和后续诊断。最终的微生物诊断包括SARS-CoV-2(COVID-19)、支原体肺炎、甲型流感、呼吸道合胞病毒、非SARS/MERS冠状病毒、鼻病毒/肠道病毒。9/68患者接受了抗菌药物治疗,15/68患者进入负压室,其中5/68患者仅因无法在家隔离而入院。需要临床入院或抗菌药物治疗(14/68)的患者与不需要入院或抗菌药物的患者相似,在临床入院/抗菌药物组中,发烧和呼吸短促的患者略多。最常用的抗菌药物是强力霉素、莫西沙星和奥司他韦。大多数患者病情较轻,无需临床干预。文章结果支持了这一种依赖临床医生的社区测试方法,以用来评估更多不适患者的比例。 *注,本文为预印本论文手稿,是未经同行评审的初步报告,其观点仅供科研同行交流,并不是结论性内容,请使用者谨慎使用. 4.附件: 原文链接 https://www.medrxiv.org/content/10.1101/2020.02.29.20029462v1